IBUPROFEN
NDC 51662-1582, IBUPROFEN, suspension, from HF Acquisition Co LLC, DBA HealthFirst.
- Product NDC
- 51662-1582
- Status
- Listed
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA209207
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1582 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IBUPROFEN100 mg/5mL
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51662-1582-1 | 51662158201 | 120 mL in 1 BOTTLE (51662-1582-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 51662-1582 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51662-1582 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51662-1582. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.